Percutaneous Treatment of Non-parasitic Splenic Cysts: Long-Term Results for Single- Versus Multiple-Session Treatment
Autor: | Okan Akhan, Cigdem Ozer, Devrim Akinci, Merve Gulbiz Dagoglu-Kartal, Turkmen Ciftci, Aysun Erbahceci |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
Male medicine.medical_specialty Percutaneous medicine.medical_treatment Group B 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Sclerotherapy medicine Paracentesis Humans Radiology Nuclear Medicine and imaging Retrospective Studies Splenic Diseases medicine.diagnostic_test business.industry Cysts Retrospective cohort study Interventional radiology Middle Aged medicine.disease Surgery Treatment Outcome 030220 oncology & carcinogenesis Retreatment Female Radiology Splenic disease Cardiology and Cardiovascular Medicine Complication business Follow-Up Studies |
Zdroj: | Cardiovascular and interventional radiology. 40(9) |
ISSN: | 1432-086X |
Popis: | The aim of this study was to investigate the efficacy and safety of percutaneous sclerotherapy for non-parasitic splenic cysts (NPSCs). The secondary aims were to introduce puncture-aspiration-injection-reaspiration (PAIR) technique in the treatment of NPSCs and to compare multiple- and single-session techniques. This retrospective study included 24 (17 females, 7 males) patients, treated between the years 1997 and 2015. Three techniques were used. Group A (n = 8), Group B (n = 6) and Group C (n = 10) were treated by PAIR, single-session catheterization and multiple-session catheterization, respectively. Since both PAIR and single-session catheterization techniques are carried out in a single session, Group A and Group B were evaluated in one group (Group A + B). Group A + B was compared with Group C in terms of patient demographics, the initial volume of the cysts, follow-up periods, complication and hospitalization rates and follow-up results. Recurrence and reduction rates were evaluated for two groups. Technical success rate was 100%. The mean follow-up period was 68.9 months. Recurrence detected in 7 (29.1%) patients. Final reduction rate was between 40.7 and 100% (median 96.4%) with a significant difference in cyst volume (p |
Databáze: | OpenAIRE |
Externí odkaz: |